Cardiome Pharma reports net lack of $7.

today reported financial outcomes for the second quarter and six months ended June 30, 2015. Amounts, unless specified in any other case, are expressed in U.S. Dollars and in accordance with generally accepted accounting principles used in america of America . Summary Results Cardiome documented a net lack of $7.4 million for the three months ended June 30, 2015, in comparison to a net loss of $4.2 million for the three months ended June 30, 2014. On a year-to-date basis, Cardiome recorded a net loss of $11.2 million for the six months ended June 30, 2015, in comparison to a net loss of $7.4 million for the six months ended June 30, 2014.Relating to Bloomberg: An assessment of FDA papers by Bloomberg News discovered that similar activities on quality lab tests have happened at a large number of other companies’ plant life across India that produce drug ingredients and supplements for export to the U.S. Without as noticeable as the lifeless frogs and flies inspectors have got found in various other Indian labs, the design of data integrity breaches concerns doctors in the U.S. And somewhere else. They say they dread prescribing generic medications that may not perform what they’re likely to.